Annual Drug Patent Expirations for NUPLAZID
Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two NDAs. It is available from one supplier. There are eighteen patents protecting this drug.
Drug patent litigation for NUPLAZID.
This drug has one hundred and thirty-three patent family members in twenty-seven countries.
The generic ingredient in NUPLAZID is pimavanserin tartrate. One supplier is listed for this compound. Additional details are available on the pimavanserin tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
